Status:
COMPLETED
Safety and Efficacy of a Glaucoma Drug Delivery System
Lead Sponsor:
Vistakon Pharmaceuticals
Conditions:
Glaucoma, Open-Angle
Ocular Hypertension
Eligibility:
All Genders
21+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the ocular safety and efficacy of a glaucoma drug delivery system in open-angle glaucoma or ocular hypertension.
Eligibility Criteria
Inclusion
- Man or woman 21 years of age or greater
- must have open angle glaucoma or ocular hypertension.
- Corrected visual acuity in each eye of 20/200 or better.
Exclusion
- Previous glaucoma intraocular surgery or refractive surgery.
- Planned contact lens use during the study.
- Clinically significant ocular or systemic disease that might interfere with the study.
- Use of chronic corticosteroids by any route.
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT00824720
Start Date
December 1 2008
End Date
April 1 2009
Last Update
March 6 2015
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Artesia, California, United States
2
Louisville, Kentucky, United States
3
Baltimore, Maryland, United States, USA
4
Mt. Pleasant, South Carolina, United States